{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:54:39Z","timestamp":1788818079647,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The study was funded by the collaboration agreement between Karolinska Institutet and Stockholm County Council (ALF). Per Svenningsson is a Wallenberg Clinical Scholar."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Polyneuropathy (PNP) has been reported to be a possible phenotypic feature in Gaucher disease type 1 (GD1), while less is known about PNP in type 3 (GD3). We performed a cross-sectional study, exploring PNP in a Swedish GD cohort. Clinical assessment and blood biochemistry were carried out in 8 patients with GD1 and 11 patients with GD3. In patients with symptoms or clinical findings indicative of PNP, nerve conduction studies and quantitative sensory testing were performed. Assessments were compared to historic controls. A subclinical small fiber neuropathy (SFN) was demonstrated in 2 of 8 patients in the significantly (p\u2009=\u20090,021) older GD1 cohort. A large fiber PNP was evident in an additional 3 GD1 patients but could not be ascribed as disease manifestation. No GD3 patients exhibited neurophysiological evidence of small or large fiber PNP attributed to GD3. Compared to historic controls, no significant group differences were evident with regard to neuropathy rating scores. In summary, our study does not support large fiber PNP as a prevalent manifestation of GD. SFN is a possible feature in GD1, although small sample size limits definite conclusions. Our study provides novel data, arguing against clinically significant small or large fiber PNP in GD3.<\/jats:p>","DOI":"10.1038\/s41598-019-51976-2","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T18:34:30Z","timestamp":1572028470000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Polyneuropathy in Gaucher disease type 1 and 3 \u2013 a descriptive case series"],"prefix":"10.1038","volume":"9","author":[{"given":"Mattias","family":"Andr\u00e9asson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ran","family":"Solders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia K.","family":"Bj\u00f6rkvall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Machaczka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Svenningsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,25]]},"reference":[{"key":"51976_CR1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2147\/BTT.S7582","volume":"4","author":"TM Cox","year":"2010","unstructured":"Cox, T. M. Gaucher disease: clinical profile and therapeutic developments. Biologics 4, 299\u2013313, https:\/\/doi.org\/10.2147\/BTT.S7582 (2010).","journal-title":"Biologics"},{"key":"51976_CR2","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ymgme.2007.03.009","volume":"91","author":"S Mercimek-Mahmutoglu","year":"2007","unstructured":"Mercimek-Mahmutoglu, S. et al. Neurological and brain MRS findings in patients with Gaucher disease type 1. Mol Genet Metab 91, 390\u2013395, https:\/\/doi.org\/10.1016\/j.ymgme.2007.03.009 (2007).","journal-title":"Mol Genet Metab"},{"key":"51976_CR3","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s10354-010-0850-x","volume":"160","author":"GM Pastores","year":"2010","unstructured":"Pastores, G. M. Neuropathic Gaucher disease. Wien Med Wochenschr 160, 605\u2013608, https:\/\/doi.org\/10.1007\/s10354-010-0850-x (2010).","journal-title":"Wien Med Wochenschr"},{"key":"51976_CR4","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.neuron.2017.01.018","volume":"93","author":"E Aflaki","year":"2017","unstructured":"Aflaki, E., Westbroek, W. & Sidransky, E. The Complicated Relationship between Gaucher Disease and Parkinsonism: Insights from a Rare Disease. Neuron 93, 737\u2013746, https:\/\/doi.org\/10.1016\/j.neuron.2017.01.018 (2017).","journal-title":"Neuron"},{"key":"51976_CR5","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10545-008-0832-y","volume":"31","author":"M Biegstraaten","year":"2008","unstructured":"Biegstraaten, M., van Schaik, I. N., Aerts, J. M. & Hollak, C. E. \u2018Non-neuronopathic\u2019 Gaucher disease reconsidered. Prevalence of neurological manifestations in a Dutch cohort of type I Gaucher disease patients and a systematic review of the literature. J Inherit Metab Dis 31, 337\u2013349, https:\/\/doi.org\/10.1007\/s10545-008-0832-y (2008).","journal-title":"J Inherit Metab Dis"},{"key":"51976_CR6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10545-010-9095-5","volume":"33","author":"P Cherin","year":"2010","unstructured":"Cherin, P. et al. The neurological manifestations of Gaucher disease type 1: the French Observatoire on Gaucher disease (FROG). J Inherit Metab Dis 33, 331\u2013338, https:\/\/doi.org\/10.1007\/s10545-010-9095-5 (2010).","journal-title":"J Inherit Metab Dis"},{"key":"51976_CR7","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1093\/brain\/awq198","volume":"133","author":"M Biegstraaten","year":"2010","unstructured":"Biegstraaten, M. et al. Peripheral neuropathy in adult type 1 Gaucher disease: a 2-year prospective observational study. Brain 133, 2909\u20132919, https:\/\/doi.org\/10.1093\/brain\/awq198 (2010).","journal-title":"Brain"},{"key":"51976_CR8","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1001\/archneur.60.9.1296","volume":"60","author":"DS Saperstein","year":"2003","unstructured":"Saperstein, D. S. et al. Challenges in the identification of cobalamin-deficiency polyneuropathy. Arch Neurol 60, 1296\u20131301, https:\/\/doi.org\/10.1001\/archneur.60.9.1296 (2003).","journal-title":"Arch Neurol"},{"key":"51976_CR9","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/ng.2386","volume":"44","author":"D Coelho","year":"2012","unstructured":"Coelho, D. et al. Mutations in ABCD4 cause a new inborn error of vitamin B12 metabolism. Nat Genet 44, 1152\u20131155, https:\/\/doi.org\/10.1038\/ng.2386 (2012).","journal-title":"Nat Genet"},{"key":"51976_CR10","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1007\/s00018-011-0861-9","volume":"68","author":"H Zhao","year":"2011","unstructured":"Zhao, H., Brunk, U. T. & Garner, B. Age-related lysosomal dysfunction: an unrecognized roadblock for cobalamin trafficking? Cell Mol Life Sci 68, 3963\u20133969, https:\/\/doi.org\/10.1007\/s00018-011-0861-9 (2011).","journal-title":"Cell Mol Life Sci"},{"key":"51976_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fmolb.2016.00027","volume":"3","author":"L Hannibal","year":"2016","unstructured":"Hannibal, L. et al. Biomarkers and Algorithms for the Diagnosis of Vitamin B12 Deficiency. Front Mol Biosci 3, 27, https:\/\/doi.org\/10.3389\/fmolb.2016.00027 (2016).","journal-title":"Front Mol Biosci"},{"key":"51976_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2326409817692359","volume":"5","author":"L Hannibal","year":"2017","unstructured":"Hannibal, L. et al. Hampered Vitamin B12 Metabolism in Gaucher Disease? Journal of Inborn Errors of Metabolism and Screening 5, 1\u20137, https:\/\/doi.org\/10.1177\/2326409817692359 (2017).","journal-title":"Journal of Inborn Errors of Metabolism and Screening"},{"key":"51976_CR13","first-page":"115:E117ER","volume":"115","author":"A Danielsson","year":"2018","unstructured":"Danielsson, A. Alkoholberoende ett f\u00f6r\u00e4nderligt tillst\u00e5ende av varierande grad. L\u00e4kartidningen 115, 115:E117ER (2018).","journal-title":"L\u00e4kartidningen"},{"key":"51976_CR14","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1529-8027.2008.00180.x","volume":"13","author":"JR Singleton","year":"2008","unstructured":"Singleton, J. R. et al. The Utah Early Neuropathy Scale: a sensitive clinical scale for early sensory predominant neuropathy. J Peripher Nerv Syst 13, 218\u2013227, https:\/\/doi.org\/10.1111\/j.1529-8027.2008.00180.x (2008).","journal-title":"J Peripher Nerv Syst"},{"key":"51976_CR15","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s10545-011-9347-z","volume":"34","author":"EH Davies","year":"2011","unstructured":"Davies, E. H. et al. Four-year follow-up of chronic neuronopathic Gaucher disease in Europeans using a modified severity scoring tool. J Inherit Metab Dis 34, 1053\u20131059, https:\/\/doi.org\/10.1007\/s10545-011-9347-z (2011).","journal-title":"J Inherit Metab Dis"},{"key":"51976_CR16","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1212\/WNL.0b013e31823a0ee4","volume":"77","author":"YA Rajabally","year":"2011","unstructured":"Rajabally, Y. A. & Martey, J. Neuropathy in Parkinson disease: prevalence and determinants. Neurology 77, 1947\u20131950, https:\/\/doi.org\/10.1212\/WNL.0b013e31823a0ee4 (2011).","journal-title":"Neurology"},{"key":"51976_CR17","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3233\/JPD-171127","volume":"7","author":"M Andreasson","year":"2017","unstructured":"Andreasson, M., Brodin, L., Laffita-Mesa, J. M. & Svenningsson, P. Correlations Between Methionine Cycle Metabolism, COMT Genotype, and Polyneuropathy in L-Dopa Treated Parkinson\u2019s Disease: A Preliminary Cross-Sectional Study. J Parkinsons Dis 7, 619\u2013628, https:\/\/doi.org\/10.3233\/JPD-171127 (2017).","journal-title":"J Parkinsons Dis"},{"key":"51976_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0700-7","volume":"12","author":"G Devigili","year":"2017","unstructured":"Devigili, G. et al. Chronic pain in Gaucher disease: skeletal or neuropathic origin? Orphanet J Rare Dis 12, 148, https:\/\/doi.org\/10.1186\/s13023-017-0700-7 (2017).","journal-title":"Orphanet J Rare Dis"},{"key":"51976_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/BF00441578","volume":"133","author":"S Dreborg","year":"1980","unstructured":"Dreborg, S., Erikson, A. & Hagberg, B. Gaucher disease\u2013Norrbottnian type. I. General clinical description. Eur J Pediatr 133, 107\u2013118 (1980).","journal-title":"Eur J Pediatr"},{"key":"51976_CR20","doi-asserted-by":"publisher","first-page":"212 e215","DOI":"10.1016\/j.neurobiolaging.2016.04.022","volume":"45","author":"C Ran","year":"2016","unstructured":"Ran, C. et al. Strong association between glucocerebrosidase mutations and Parkinson\u2019s disease in Sweden. Neurobiol Aging 45, 212 e215\u2013212 e211, https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.04.022 (2016).","journal-title":"Neurobiol Aging"},{"key":"51976_CR21","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/mds.25248","volume":"28","author":"R Duran","year":"2013","unstructured":"Duran, R. et al. The glucocerobrosidase E326K variant predisposes to Parkinson\u2019s disease, but does not cause Gaucher\u2019s disease. Mov Disord 28, 232\u2013236, https:\/\/doi.org\/10.1002\/mds.25248 (2013).","journal-title":"Mov Disord"},{"key":"51976_CR22","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0950-3536(97)80033-9","volume":"10","author":"TM Cox","year":"1997","unstructured":"Cox, T. M. & Schofield, J. P. Gaucher\u2019s disease: clinical features and natural history. Baillieres Clin Haematol 10, 657\u2013689 (1997).","journal-title":"Baillieres Clin Haematol"},{"key":"51976_CR23","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/(SICI)1096-8628(20000320)91:3<222::AID-AJMG13>3.0.CO;2-#","volume":"91","author":"LS Finn","year":"2000","unstructured":"Finn, L. S., Zhang, M., Chen, S. H. & Scott, C. R. Severe type II Gaucher disease with ichthyosis, arthrogryposis and neuronal apoptosis: molecular and pathological analyses. Am J Med Genet 91, 222\u2013226 (2000).","journal-title":"Am J Med Genet"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51976-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51976-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51976-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T15:02:47Z","timestamp":1671289367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51976-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,25]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["51976"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-51976-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,25]]},"assertion":[{"value":"19 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.M., P.S. and C.K.B. have received honoraria for lecturing on Gaucher disease from Sanofi-Genzyme and Shire\/Takeda. M.A. and P.S. are investigators in the MOVES-PD study sponsored by Sanofi-Genzyme. The other authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15358"}}